Deadly Drugs: Johnson and Johnson’s Risperdal

Deadly Drugs: Johnson and Johnson’s Risperdal – Insider Exclusive Host and Executive Producer Steve Murphy interviews Stephen A. Sheller, Founding Partner of Sheller, PC and Co-Managing Partner Brian J. McCormick, Jr. about the evolution of the drug Risperdal® from treatment of schizophrenia and extreme bipolar mania to off-label use in children and the elderly for behavior issues, sleep problems, and other uses, some which later became approved by the FDA. What is the cautionary tale? How are consumers and patients affected by the marketing of antipsychotic drugs?

OxyContin drug scandal hits Ontario

Filed under: drug treatment news

Reports of illicit use of the powerful painkiller OxyContin, and the epidemic levels of addiction to the pills, frustrate him because he says he is one of the thousands of people across the province who legitimately needs the medication. He has been …
Read more on Toronto Sun